Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Proceeding of Mulawarman Pharmaceuticals Conferences
Enjelina Natasya Sihite
Laboratorium Penelitian dan Pengembangan Kefarmasian “Farmaka Tropis”, Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Evaluasi Penggunaan Antibiotik Secara Kuantitatif dan Kualitatif Pada Pasien Bedah Digestif di RSUD Abdul Wahab Sjahranie Samarinda: Quantitative and Qualitative Evaluation of Antibiotic Use in Digestive Surgery Patients at Abdul Wahab Sjahranie Hospital Samarinda Enjelina Natasya Sihite; Adam M. Ramadhan; Erwin Samsul
Proceeding of Mulawarman Pharmaceuticals Conferences Vol. 14 (2021): Proceeding of Mulawarman Pharmaceuticals Conferences
Publisher : Fakultas Farmasi, Universitas Mulawarman, Samarinda, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (328.028 KB) | DOI: 10.25026/mpc.v14i1.552

Abstract

Antibiotics are drugs that are the most widely prescribed to treat bacterial infections. Prescription of high and not wise antibiotics has a detrimental impact: increasing antibiotic resistance. This study aimed to determine patient characteristics, quantity, and quality of antibiotic use in digestive surgery patients at Abdul Wahab Sjahranie Hospital Samarinda from January-December 2020. This study is a retrospective observational study with data collection techniques using the purposive sampling method. The results obtained 75 medical records, with the majority of the adults (26-45 years old) were 35 patients (48%), men were 45 patients (60%), length of stay 4-5 days were 30 patients (40%), private workers were 23 patients (30.7%), and type of disease appendicitis were 27 patients (36%). The most used antibiotic is ceftriaxone, which is 64.41 DDD/100 patient days, and antibiotics included in segment 90% were ceftriaxone and metronidazole. The quality of antibiotic use was 54.91% included in category 0 including ceftriaxone, metronidazole, cefpirom, and levofloxacin, category IIIB as 35.26% including ceftriaxone, metronidazole, cefpirom, and cefixime, category IIIA as 4.05% including ceftriaxone and metronidazole, the IVC category as 4.62% including ceftriaxone and cefixime, and IVA as 1.16% including metronidazole.
Co-Authors Adam M. Ramadhan Erwin Samsul